Andrew Copestake

Chief Commercial Officer at Clinipace


Dr. Copestake is an entrepreneurial, commercially focused, senior executive with almost 30 years of experience in the pharmaceutical, biotechnology, and CRO industries. He has held positions across the sector at all levels from academic researcher to Chief Executive and has gained significant international experience from working in global positions and during assignments in the US, Japan, and throughout Europe. Andrew has also held numerous board-level positions driving corporate strategy and fund-raising and has become an expert in pharmaceutical, biotechnology & CRO business development, general management, partnering (in-/out-licensing), and product development with a successful track record of delivering sales, growth, and enhancing profitability. He is a strong, decisive leader with an ability to manage businesses through significant change while delivering key performance indicators.

Andrew holds a Ph.D. in Respiratory & Exercise Physiology from Loughborough University, UK, and a Bachelor's Degree (Hons) in Applied Biology from East London University, UK. He is also a Fellow of the Royal Society of Medicine.



  • Chief Commercial Officer

    Current role

View in org chart